# FDA shortage status: Pentostatin Injection

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 1
- Latest FDA row update: 2026-08-27
- Retrieved: 2026-08-28T02:58:09+00:00

## FDA package and manufacturer records

- Hospira, Inc., a Pfizer Company — Nipent, Injection, 10 mg, single dose vial  (NDC 0409-0801-01) — FDA availability: Unavailable — updated: 2026-08-27

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/pentostatin-injection)
- [JSON record](https://citefacts.com/shortages/pentostatin-injection.json)